Island Pharmaceuticals Limited (ILA.AX)
AUD 0.17
(-5.71%)
AUD 0.17
(-5.71%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -2.87 Million AUD | 1.18% |
| 2023 | -2.9 Million AUD | -3.53% |
| 2022 | -2.8 Million AUD | -31.33% |
| 2021 | -2.13 Million AUD | -324967.33% |
| 2020 | -658.00 AUD | 99.85% |
| 2019 | -430 Thousand AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 FY | -4.12 Million AUD | -41.86% |
| 2024 Q4 | -1.34 Million AUD | 0.0% |
| 2024 Q2 | -2.13 Million AUD | -263.59% |
| 2024 Q3 | -1.34 Million AUD | 37.06% |
| 2024 Q1 | -586.25 Thousand AUD | 53.87% |
| 2023 Q2 | -1.63 Million AUD | -100.0% |
| 2023 Q1 | -818.66 Thousand AUD | 56.32% |
| 2023 FY | -2.9 Million AUD | -3.53% |
| 2023 Q4 | -1.27 Million AUD | -101.76% |
| 2023 Q3 | -629.87 Thousand AUD | 61.53% |
| 2022 Q3 | -937.09 Thousand AUD | -0.24% |
| 2022 Q4 | -1.87 Million AUD | -100.0% |
| 2022 FY | -2.8 Million AUD | -31.33% |
| 2022 Q2 | -934.82 Thousand AUD | -100.0% |
| 2022 Q1 | -467.41 Thousand AUD | 78.15% |
| 2021 Q1 | -41.00 AUD | 0.0% |
| 2021 FY | -2.13 Million AUD | -324967.33% |
| 2021 Q4 | -2.13 Million AUD | -100.0% |
| 2021 Q3 | -1.06 Million AUD | -2608265.85% |
| 2021 Q2 | -41.00 AUD | 0.0% |
| 2020 FY | -658.00 AUD | 99.85% |
| 2019 FY | -430 Thousand AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AdAlta Limited | -5.26 Million AUD | 45.382% |
| Acrux Limited | -9.83 Million AUD | 70.777% |
| Botanix Pharmaceuticals Limited | -14.69 Million AUD | 80.45% |
| BTC Health Limited | 1.05 Million AUD | 372.322% |
| Chimeric Therapeutics Limited | -12.3 Million AUD | 76.654% |
| Clarity Pharmaceuticals Ltd | -44.8 Million AUD | 93.585% |
| Clinuvel Pharmaceuticals Limited | 49.14 Million AUD | 105.847% |
| Biome Australia Limited | -1.91 Million AUD | -50.205% |
| Hexima Limited | -1 Million AUD | -184.885% |
| Immutep Limited | -44.93 Million AUD | 93.605% |
| Memphasys Limited | -2.7 Million AUD | -6.279% |
| Neuren Pharmaceuticals Limited | 225.96 Million AUD | 101.272% |
| Noxopharm Limited | -7.53 Million AUD | 61.861% |
| Prescient Therapeutics Limited | -7.18 Million AUD | 60.011% |
| Race Oncology Limited | -13.38 Million AUD | 78.523% |
| Radiopharm Theranostics Limited | -47.2 Million AUD | 93.913% |
| Starpharma Holdings Limited | -15.15 Million AUD | 81.042% |
| Tissue Repair Ltd | -4.87 Million AUD | 41.062% |
| Biotron Limited | -5.15 Million AUD | 44.211% |
| Alterity Therapeutics Limited | -19.6 Million AUD | 85.339% |
| CSL Limited | 5.64 Billion AUD | 100.051% |
| EZZ Life Science Holdings Limited | 9.71 Million AUD | 129.576% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -96.952% |
| Bio-Gene Technology Limited | -3.06 Million AUD | 6.161% |
| Zelira Therapeutics Limited | -5.93 Million AUD | 51.605% |
| Patrys Limited | -3.53 Million AUD | 18.8% |
| Orthocell Limited | -11.68 Million AUD | 75.398% |
| Imugene Limited | -140.93 Million AUD | 97.961% |
| PYC Therapeutics Limited | -38.85 Million AUD | 92.604% |
| Proteomics International Laboratories Limited | -7.23 Million AUD | 60.261% |
| Cynata Therapeutics Limited | -8.8 Million AUD | 67.373% |
| Arovella Therapeutics Limited | -7.19 Million AUD | 60.048% |
| Nanollose Limited | -1.24 Million AUD | -129.935% |
| Invex Therapeutics Ltd | -2.13 Million AUD | -34.69% |
| NeuroScientific Biopharmaceuticals Limited | -2.05 Million AUD | -39.737% |
| Amplia Therapeutics Limited | -4.42 Million AUD | 35.055% |
| Nyrada Inc. | -4.56 Million AUD | 36.983% |
| Telix Pharmaceuticals Limited | - AUD | Infinity% |
| Dimerix Limited | -25.05 Million AUD | 88.532% |
| PharmAust Limited | -6.65 Million AUD | 56.841% |
| AnteoTech Limited | -11.72 Million AUD | 75.493% |
| Paradigm Biopharmaceuticals Limited | -65.11 Million AUD | 95.586% |
| Recce Pharmaceuticals Ltd | -22.05 Million AUD | 86.968% |
| Avecho Biotechnology Limited | -4.58 Million AUD | 37.379% |
| Actinogen Medical Limited | -12.83 Million AUD | 77.617% |
| Immuron Limited | -5.8 Million AUD | 50.462% |
| Argenica Therapeutics Limited | -5.67 Million AUD | 49.327% |